Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Probuphine obtains FDA priority review designation for opioid dependence

Jan. 3, 2013

ALKS-5461 as a novel combination therapy for the treatment of cocaine abuse

Dec. 19, 2012

EMA committee recommends approval of Selincro for alcohol dependence

Dec. 17, 2012

Omeros patents new anti-MASP-2 monoclonal antibodies

Dec. 7, 2012

Varenicline as a potential treatment for methamphetamine dependence

Dec. 7, 2012

Phase IIa trial begins of MediciNova's ibudilast

Nov. 22, 2012

FDA assigns action date for Orexo's Zubsolv NDA

Nov. 19, 2012

Catalyst Pharmaceutical reports results from phase IIb CPP-109 trial

Nov. 9, 2012

ADX-71441 shows promise in preclinical model of alcohol binge drinking

Oct. 30, 2012

DepoVax found to enhance effect of investigational cocaine vaccine

Oct. 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...